ADVOCATE. CONNECT. INNOVATE.

Category Archives: Sacramento

Privacy to Again be a Major Issue in California in 2020

The enactment of the California Consumer Privacy Act of 2018 (AB 375) (CCPA) brought sweeping restrictions on the collection and use of consumer information. A clean-up bill that same year, SB 1121 (Dodd), added key exceptions to the CCPA to help protect clinical trials and other biomedical research from unintended consequences, including exceptions for, among other things, protected health information (PHI) under federal law and information collected as part of a clinical trial subject to various laws and guidelines.

2019 State Legislative Year in Review

While the 2018 legislative year marked arguably the most successful year ever for CLSA in Sacramento and provided a number of major policy issues on which to focus our energy, the 2019 legislative year was “death by a thousand cuts,” requiring CLSA to spread its attention broadly across a host of issues outside of our traditional areas of focus.

CLSA Helps Educate Members of State Legislature with Life Sciences Company Tours at Allergan and Edwards Lifesciences

On Oct. 22, CLSA, in partnership with Allergan and Edwards Lifesciences, hosted facility tour and roundtable discussion with the nearly 40 personnel, including state legislators, legislative staff, the Orange County Medical Association, and other key stakeholders to educate policymakers and stakeholders on the value of life sciences innovation in Orange County.

CLSA Op-Ed in CALMatters: California leads the way in precision medicine

Precision medicine uses some of the world’s most sophisticated technologies to find the root causes of each patient’s unique condition and apply the best, most precise treatments. California is a biomedical juggernaut, and the precision medicine research being funded today will impact patients around the world. Learn how California is leading the way in precision medicine research.

New Legislator Spotlight: State Senator Tom Umberg (D-Santa Ana)

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Senator Tom Umberg (D-Santa Ana). We look forward to working with Senator Umberg and his team to advance policies that improve patient health and bring positive change for California patients and their families.

New Legislator Spotlight: State Senator Lena Gonzalez (D-Long Beach)

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Senator Lena Gonzalez (D-Long Beach). We look forward to working with Senator Gonzalez and her team to advance policies that improve patient health and bring positive change for California patients and their families.

CLSA Awaits Governor Newsom’s Decision on Numerous Bills

While fewer bills directly targeting the biopharmaceutical industry were introduced this year, which was likely due in large part to Governor Newsom’s executive order on state prescription purchasing, CLSA strongly supported several bills that reached the Governor’s desk and helped prevent a number of bills of concern from reaching his desk.